Eye (London, England) · 2026
Influence of inflammatory and metabolic factors on keratoconus risk: a causal inference analysis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hysi Pirro G, Hardcastle Alison J, Davidson Alice E, Szczotka-Flynn Loretta, Khawaja Anthony P, Liskova Petra, Iyengar Sudha, Hammond Chris J, Tuft Stephen J
Аннотация
BACKGROUND: Keratoconus is a complex disease of the cornea, in part caused by environmental exposures whose nature is not fully understood.
METHODS: This study relied on previously published results from genome-wide association studies of European ancestry. Summary statistics of available genome-wide association studies on atopy, chronic inflammatory disease and serum glucose levels; results were paired with genomic association results for keratoconus into a well-powered and hypothesis-driven Mendelian Randomisation to statistically test the causal role that may have over keratoconus risk.
RESULTS: Our results confirm a higher risk of keratoconus in patients having any atopic disease (OR = 1.84, 95%CI = 1.52-2.22), but also other chronic inflammatory conditions such as rheumatoid arthritis (ORIVW = 1.11, 95%CI = 1.04-1.18) and Crohn's Disease (ORIVW = 1.08, 95%CI = 1.02-1.15). Also, higher glucose levels considerably reduced keratoconus risk (ORIVW = 0.49, 95% CI = 0.33-0.72) CONCLUSIONS: Our results suggest that, in addition to atopy, exposure to specific types of systemic inflammatory responses that develop into chronic conditions may increase keratoconus risk. These results will help clinicians to better evaluate the overall keratoconus risk, disease severity and potentially its progression. In conjunction with individual genetic risk profiles, the presence of exposure to atopic disease, high eosinophil counts and comorbidities could have an important predictive role.
METHODS: This study relied on previously published results from genome-wide association studies of European ancestry. Summary statistics of available genome-wide association studies on atopy, chronic inflammatory disease and serum glucose levels; results were paired with genomic association results for keratoconus into a well-powered and hypothesis-driven Mendelian Randomisation to statistically test the causal role that may have over keratoconus risk.
RESULTS: Our results confirm a higher risk of keratoconus in patients having any atopic disease (OR = 1.84, 95%CI = 1.52-2.22), but also other chronic inflammatory conditions such as rheumatoid arthritis (ORIVW = 1.11, 95%CI = 1.04-1.18) and Crohn's Disease (ORIVW = 1.08, 95%CI = 1.02-1.15). Also, higher glucose levels considerably reduced keratoconus risk (ORIVW = 0.49, 95% CI = 0.33-0.72) CONCLUSIONS: Our results suggest that, in addition to atopy, exposure to specific types of systemic inflammatory responses that develop into chronic conditions may increase keratoconus risk. These results will help clinicians to better evaluate the overall keratoconus risk, disease severity and potentially its progression. In conjunction with individual genetic risk profiles, the presence of exposure to atopic disease, high eosinophil counts and comorbidities could have an important predictive role.